Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

(2011) V. Corbo et al.   ANNALS OF ONCOLOGY

Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas

(2011) De-shen Wang et al.   TUMOR BIOLOGY

Induction of p53 Renders ATM-Deficient Mice Refractory to Hepatocarcinogenesis

(2009) Narci Teoh et al.   GASTROENTEROLOGY

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

(2008) T. R. Halfdanarson et al.   ANNALS OF ONCOLOGY

Prognostic significance ofataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer

(2008) Jinliang Xing et al.   CANCER

Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution

(2008) S. Ekeblad et al.   CLINICAL CANCER RESEARCH

The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma

(2008) Shikha Bose et al.   JOURNAL OF PATHOLOGY

Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer

(2007) Bin Kang et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS